MedPath

The 3D Cohort Study (Design, Develop, Discover)

Active, not recruiting
Conditions
Pregnancy Outcome
Registration Number
NCT03113331
Lead Sponsor
Université de Sherbrooke
Brief Summary

The 3D Cohort Study (Design, Develop, Discover) was established to help bridge knowledge gaps about the links between various adverse exposures during pregnancy with birth outcomes and later health outcomes in children.

Detailed Description

The main objective of the 3D study is to create a large pregnancy and birth cohort, allowing for the assessment of the effects of combined prenatal exposure on both birth outcomes and longer-term infant and child health. The specific objectives are to:

1. Determine the effects of pre- and post-natal exposures to environmental contaminants, nutritional factors and psychosocial stress on pregnancy and neurodevelopmental outcomes;

2. Assess the contribution of social, genetic, epigenetic, nutritional and environmental factors to the etiology and outcomes of intrauterine growth restriction (IUGR) and preterm birth; and

3. Assess the effects of assisted reproductive technologies (ART) on indicators of epigenetic modifications, and the relationship between such epigenetic changes and infant neurodevelopmental, cardiovascular, and metabolic outcomes.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
2366
Inclusion Criteria
  • Able to communicate in French or English
Exclusion Criteria
  • Current intravenous drug use
  • Severe illnesses or life threatening conditions
  • Multiple gestation pregnancies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intrauterine growth restrictionAt delivery

Birth weight smaller than 10th percentile

Neurodevelopment - Sensory ProfileWhen infants are 2 years old

Neurodevelopmental assessment of the infant. Test used : Sensory Profile questionnaire. This test was done on 1520 children.

Preterm birthAt delivery

Delivery before 37 weeks of gestation

Neurodevelopment - ABASWhen infants are 2 years old

Neurodevelopmental assessment of the infant. Test used : Bayley Adaptive Behaviour Questionnaire (ABAS-II). This test was done on 1520 children.

Neurodevelopment - BayleyWhen infants are 2 years old

Neurodevelopmental assessment of the infant. Test used : Bayley Scales of Infant and Toddler Development (BSID-III; cognitive scale and motor scale combined). This test was done on 1520 children.

Neurodevelopment - MacArthur-BatesWhen infants are 2 years old

Neurodevelopmental assessment of the infant. Test used : MacArthur Communicative Development Inventories (CDI; French, English, Spanish and/or Mandarin). This test was done on 1520 children.

Neurodevelopment - M-CHATWhen infants are 2 years old

Neurodevelopmental assessment of the infant. Test used : Modified Checklist of Autism in Toddlers (M-CHAT). This test was done on 1520 children.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Sainte-Justine

🇨🇦

Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath